Home›Companies›Biotech & Pharma›Rhinal Therapeutics

Rhinal Therapeutics Inc.

Develops nasal powder treatments for people with conditions including obesity and diabetes.

No LinkedIn page we could confirm. Why?
Updated Nov 17, 2026·Latest SEC filing Aug 7, 2025·Suggest an edit

About Rhinal Therapeutics

Rhinal Therapeutics is a private company based in Las Vegas, Nevada, incorporated in 2023 in Nevada. It has reported $20,000 raised in one offering on Form D since August 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 28, 2025Aug 7, 2025$20,000of $1.0M target1$20,000EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Rhinal Therapeutics's Form D filed Aug 7, 2025.

LF
Lawrence Fox
Co-Founder and Chief of Operations Officer, director
MG
Mike George
Director
AP
Austin Panhans
Chief Financial Officer
FP
Frank Puglisi
Co-founder, Chief Clinical Officer and director
RC
Robert Clayborough
Chief Scientific Officer and director

Sources

  1. SECRhinal Therapeutics Inc. filing history